Article Text
Editorial
To scan or not to scan your Parkinson patient: that is the question!
Statistics from Altmetric.com
Footnotes
Contributors RA prepared the original draft and provided significant input to later versions of the manuscript. AvR provided significant contributions to earlier versions of the manuscript. BB provided the idea for the manuscript, contributed to its early design and reviewed the final version of the manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Commissioned. Externally peer-reviewed by Simon Lewis, Sydney, Australia, and Ed Newman, Glasgow, UK.
Linked Articles
- A difficult case
Read the full text or download the PDF:
Other content recommended for you
- Improving the diagnostic accuracy in parkinsonism: a three-pronged approach
- Parkinson's disease: chameleons and mimics
- Role of brain imaging in early parkinsonism
- Progressive supranuclear palsy: diagnosis and management
- Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes
- The role of DAT-SPECT in movement disorders
- Genetics of Parkinson’s disease and related disorders
- Fifty years of progressive supranuclear palsy
- Is it Parkinson’s disease, and if not, what is it?
- A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes